Abdul Mutlib

3.4k total citations
61 papers, 2.5k citations indexed

About

Abdul Mutlib is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Abdul Mutlib has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Pharmacology and 12 papers in Oncology. Recurrent topics in Abdul Mutlib's work include Pharmacogenetics and Drug Metabolism (19 papers), Drug Transport and Resistance Mechanisms (10 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Abdul Mutlib is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Drug Transport and Resistance Mechanisms (10 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Abdul Mutlib collaborates with scholars based in United States, Canada and Australia. Abdul Mutlib's co-authors include Robert Espina, Amit S. Kalgutkar, Joseph T. Strupczewski, Christopher L. Shaffer, Deepak Dalvie, Iain Gardner, Yasuhiro Nakai, John P. O’Donnell, Jason Boer and Kirk R. Henne and has published in prestigious journals such as Analytical Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Abdul Mutlib

61 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdul Mutlib United States	24	902	825	405	388	339	61	2.5k
Lars Weidolf Sweden	28	725 0.8×	923 1.1×	348 0.9×	315 0.8×	399 1.2×	61	3.1k
Ralph A. Stearns United States	27	715 0.8×	1.3k 1.5×	303 0.7×	370 1.0×	590 1.7×	68	2.5k
Deborah A. Nicoll‐Griffith Canada	26	1.1k 1.2×	1.2k 1.5×	495 1.2×	481 1.2×	519 1.5×	60	3.1k
George A. Doss United States	29	876 1.0×	944 1.1×	681 1.7×	497 1.3×	519 1.5×	95	2.6k
Wendel L. Nelson United States	28	1.0k 1.1×	783 0.9×	547 1.4×	349 0.9×	386 1.1×	134	2.7k
B. Michael Silber United States	21	691 0.8×	650 0.8×	185 0.5×	374 1.0×	454 1.3×	49	2.0k
Wei Tang United States	27	778 0.9×	1.3k 1.6×	292 0.7×	385 1.0×	630 1.9×	75	2.6k
Nuggehally R. Srinivas India	32	903 1.0×	488 0.6×	185 0.5×	654 1.7×	506 1.5×	254	3.4k
Donglu Zhang United States	35	1.4k 1.6×	1.2k 1.5×	273 0.7×	378 1.0×	957 2.8×	122	5.0k
Kamlesh P. Vyas United States	26	606 0.7×	854 1.0×	248 0.6×	421 1.1×	494 1.5×	58	2.3k

Countries citing papers authored by Abdul Mutlib

Since Specialization

Citations

This map shows the geographic impact of Abdul Mutlib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Mutlib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Mutlib more than expected).

Fields of papers citing papers by Abdul Mutlib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdul Mutlib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Mutlib. The network helps show where Abdul Mutlib may publish in the future.

Co-authorship network of co-authors of Abdul Mutlib

This figure shows the co-authorship network connecting the top 25 collaborators of Abdul Mutlib. A scholar is included among the top collaborators of Abdul Mutlib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdul Mutlib. Abdul Mutlib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liao, Mingxiang, Simon P. Watkins, Jeff Isaacson, et al.. (2019). Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors. Investigational New Drugs. 38(3). 765–775. 29 indexed citations

Wang, Jianyao, Linhong Deng, Robert Espina, et al.. (2010). Characterization of HKI-272 Covalent Binding to Human Serum Albumin. Drug Metabolism and Disposition. 38(7). 1083–1093. 51 indexed citations

Mutlib, Abdul, Robert Espina, Karthick Vishwanathan, et al.. (2010). Application of Quantitative NMR in Pharmacological Evaluation of Biologically Generated Metabolites: Implications in Drug Discovery. Drug Metabolism and Disposition. 39(1). 106–116. 18 indexed citations

Liu, Zhi, Abdul Mutlib, Jianyao Wang, & Rasmy Talaat. (2008). Liquid chromatography/mass spectrometry determination of endogenous plasma acetyl and palmitoyl carnitines as potential biomarkers of β ‐oxidation in mice. Rapid Communications in Mass Spectrometry. 22(21). 3434–3442. 18 indexed citations

Lam, Wing, et al.. (2007). Application of In-Line Liquid Chromatography-Accurate Radioisotope Counting-Mass Spectrometry (LC-ARC-MS) to Evaluate Metabolic Profile of [3H]-Mefenamic Acid in Rat Plasma. Drug Metabolism Letters. 1(3). 179–188. 5 indexed citations

Mutlib, Abdul, et al.. (2006). Identification of Potential Genomic Biomarkers of Hepatotoxicity Caused by Reactive Metabolites of N -Methylformamide: Application of Stable Isotope Labeled Compounds in Toxicogenomic Studies. Chemical Research in Toxicology. 19(10). 1270–1283. 13 indexed citations

Shah, Syed Ahsan Ali, et al.. (2006). Identification and Removal of Barriers for Renewable Energy Technologies in Pakistan. 397–402. 16 indexed citations

Sinclair, Jacqueline F., Stephen C. Strom, Sheryl G. Wood, et al.. (2005). Phenobarbital and Phenytoin Increased Acetaminophen Hepatotoxicity Due to Inhibition of UDP-Glucuronosyltransferases in Cultured Human Hepatocytes. Toxicological Sciences. 87(1). 146–155. 54 indexed citations

Sy, Sherwin K. B., Qiang Jiao, Andrzej Wernicki, et al.. (2003). Simultaneous quantification of seven active metabolites of roxifiban in human plasma by LC/MS/MS in the presence of an interfering displacer at millimolar concentrations. Journal of Pharmaceutical and Biomedical Analysis. 31(5). 937–951. 13 indexed citations

10.

Chen, Hao, Weiqi Chen, Liang‐Shang Gan, & Abdul Mutlib. (2003). Metabolism of (S)-5,6-Difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a Non-Nucleoside Reverse Transcriptase Inhibitor, in Human Liver Microsomes. Metabolic Activation and Enzyme Kinetics. Drug Metabolism and Disposition. 31(1). 122–132. 22 indexed citations

11.

Mutlib, Abdul, et al.. (1999). Liquid Chromatography/Mass Spectrometry and High-Field Nuclear Magnetic Resonance Characterization of Novel Mixed Diconjugates of the Non-nucleoside Human Immunodeficiency Virus-1 Reverse Transcriptase Inhibitor, Efavirenz. Drug Metabolism and Disposition. 27(9). 1045–1056. 29 indexed citations

12.

Mutlib, Abdul & Jochen Klein. (1998). Application of Liquid Chromatography/Mass Spectrometry in Accelerating the Identification of Human Liver Cytochrome P450 Isoforms Involved in the Metabolism of Iloperidone. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1285–1293. 22 indexed citations

13.

Mutlib, Abdul, et al.. (1996). Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).. Drug Metabolism and Disposition. 24(10). 1139–1150. 3 indexed citations

14.

Mutlib, Abdul, et al.. (1992). Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS.. Drug Metabolism and Disposition. 20(6). 840–848. 23 indexed citations

15.

Mutlib, Abdul, et al.. (1992). Isolation and characterization of carbinolamide and phenolic glucuronide conjugates of (+-)-N-methyl-N-(1-methyl-3,3-diphenylpropyl) formamide and N-formylmethamphetamine by FAB/MS, LC/MS/MS, and NMR.. Drug Metabolism and Disposition. 20(3). 451–460. 10 indexed citations

16.

Mutlib, Abdul & Wendel L. Nelson. (1990). Synthesis and identification of the N-glucuronides of norgallopamil and norverapamil, unusual metabolites of gallopamil and verapamil.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 593–599. 15 indexed citations

17.

Mutlib, Abdul & Wendel L. Nelson. (1990). Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the N-dealkylation processes.. Drug Metabolism and Disposition. 18(3). 331–337. 6 indexed citations

18.

Mutlib, Abdul & Wendel L. Nelson. (1990). Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the O-demethylation processes.. Drug Metabolism and Disposition. 18(3). 309–314. 9 indexed citations

19.

Mutlib, Abdul & T. R. Watson. (1989). The pharmacokinetics and tissue distribution of gomphoside in Wistar rats. European Journal of Drug Metabolism and Pharmacokinetics. 14(2). 117–125. 2 indexed citations

20.

Mutlib, Abdul, H. T. Andrew Cheung, & T. R. Watson. (1988). In vitro metabolism of the cardiotonic steroids gomphogenin and calactin. Journal of Steroid Biochemistry. 29(1). 135–143. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact